We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fertility Chip Measures Sperm Concentration and Motility

By LabMedica International staff writers
Posted on 08 Nov 2011
A lab-on chip device has been developed that that can accurately count sperm and measure their motility. More...


The chip can be inserted into a compact device for one-off use and a home test kit will soon make it possible for men to test their sperm in a familiar environment.

A doctoral candidate at the University of Twente (Enshede, The Netherlands) developed the lab-on-a-chip measures sperm concentration. On the chip, sperm flow through a liquid-filled channel, beneath electrode "bridges." When a cell passes beneath one of these electrodes, there is a brief fluctuation in the electrical resistance. These events are counted. To test the reliability of the concentration measurements, microspheres were added to the liquid and the method was selective enough to distinguish sperm from microspheres. The system was also able to distinguish reliably white blood cells from other bodies. In addition to being an indicator of sperm quality, the white cell count provides important additional information to gynecologists.

The importance of the sperm concentration is that the fertility standard states that a milliliter of ejaculate should contain at least 20 million sperm. A second important aspect of fertility is motility. This too can be measured using the lab-on-a-chip. A small adjustment of the lab-on-a-chip is all that is needed to sort motile sperm from nonmotile sperm, after which both can be counted separately. By measuring sperm motility in this way, the chip offers a complete test.

Simple home test kits are already commercially available. These indicate whether the concentration is "above or below the standard value." However, these tests are too limited, as they do not give accurate concentration readings. Loes Segerink, the PhD student, has received a grant, as a first step towards establishing a company. This will provide her with a platform for refining the fertility chip and its accompanying read-out device into a market-ready product.

Related Links:
University of Twente



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
All-in-One Molecular System
AIO M160
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.